Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 22, 2016
[ Mon, Aug 22nd 2016
] - WOPRAI
[ Mon, Aug 22nd 2016
] - WOPRAI
[ Mon, Aug 22nd 2016
] - WOPRAI
Fri, August 19, 2016
[ Fri, Aug 19th 2016
] - WOPRAI
[ Fri, Aug 19th 2016
] - WOPRAI
[ Fri, Aug 19th 2016
] - WOPRAI
[ Fri, Aug 19th 2016
] - WOPRAI
Thu, August 18, 2016
[ Thu, Aug 18th 2016
] - WOPRAI
[ Thu, Aug 18th 2016
] - WOPRAI
[ Thu, Aug 18th 2016
] - WOPRAI
[ Thu, Aug 18th 2016
] - WOPRAI
[ Thu, Aug 18th 2016
] - WOPRAI
[ Thu, Aug 18th 2016
] - WOPRAI
[ Thu, Aug 18th 2016
] - WOPRAI
[ Thu, Aug 18th 2016
] - WOPRAI
[ Thu, Aug 18th 2016
] - WOPRAI
[ Thu, Aug 18th 2016
] - WOPRAI
Wed, August 17, 2016
[ Wed, Aug 17th 2016
] - WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $368 on, Aug 17th, 2016
Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $385 to $368 on, Aug 17th, 2016.
Matthew has made no other calls on BIIB in the last 4 months.
There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Aaron Gal of "Bernstein" Initiated at Buy on, Wednesday, June 29th, 2016
Similar Stocks and Investing Articles
[ Thu, Jul 28th 2016
] - WOPRAI
[ Thu, Jul 21st 2016
] - WOPRAI
[ Tue, Sep 15th 2015
] - WOPRAI
[ Tue, Aug 11th 2015
] - WOPRAI
[ Mon, Jul 27th 2015
] - WOPRAI
[ Mon, Jul 27th 2015
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Wed, Apr 25th 2012
] - WOPRAI